STOCK-BASED COMPENSATION [Text Block] | 7. STOCK-BASED COMPENSATION Stock-based compensation includes grants of stock options and purchase warrants to eligible directors, employees and consultants as determined by the Board of Directors. Stock option plans Stock warrants Valuation of awards 1. Service-based; 2. Performance-based; and 3. Market-based. The Company used the following assumptions to estimate the fair values of the options granted for the years ended: December 31, December 31, 2016 2015 Dividend yield - - Expected volatility 65.91 – 164.23% 71.55 - 165.70% Risk-free interest rate 0.38 – 2.07% 0.02 – 1.32% Expected life (years) 0.00 – 4.00 0.10 – 4.25 Inputs used in these models are determined as follows: 1. The expected life represents the weighted-average period the awards are expected to remain outstanding and is a derived output of the option pricing models. The expected life is impacted by all of the underlying assumptions and calibration of the Company’s models. 2. The requisite service period for market-based stock option awards is a derived output of the hybrid Monte Carlo-Trinomial Lattice model. 3. Volatility is based on the average historical volatility levels of a representative peer group or the Company’s common stock depending on the life of the options. 4. The risk-free interest rate is based on the implied yield available on U.S. Treasury zero- coupon issues over the equivalent contractual lives of the options. During the year ended December 31, 2016, stock based compensation activity was as follows: a) On December 27, 2016, the Company granted stock options under the Plan to the Company’s directors, executive officers and certain employees for an aggregate of 8,070,000 shares of common stock at an exercise price of $0.08 per option. The options vest 50% each on June 30, 2017, 25% on September 30, 2017 and 25% on December 31, 2017. The options expire on the fifth anniversary of the date that they vest. b) On December 27, 2016, the Company’s Board of Directors unilaterally determined to amend 1,367,197 stock options by extending their expiration dates and reducing their exercise price to $0.08 per share. The options were granted on various dates between 2009 and 2011 and had a weighted average exercise price of $0.61 per share. The expiration dates of all of the options were extended to January 31, 2017. Additionally, the Company’s Board of Directors unilaterally determined to amend 7,600,000 stock options by temporarily reducing their exercise price to $0.08 per share for a period ending January 31, 2017. The options were granted on various dates between 2010 and 2015 and had a weighted average exercise price of $0.56 per share. After January 31, 2017, the options are exercisable under their previous terms. The Company’s Board of Directors also unilaterally determined to amend 4,800,000 warrants by extending their expiration dates and reducing their exercise price to $0.08 per share. The warrants were granted to consultants on various dates between 2009 and 2011 and had a weighted average exercise price of $0.74 per share. The expiration dates of all of the warrants were extended to January 31, 2017. Additionally, the Company’s Board of Directors unilaterally determined to amend 4,950,000 warrants by temporarily reducing their exercise price to $0.08 per share for a period ending January 31, 2017. The warrants were granted to consultants on February 26, 2016 and had a weighted average exercise price of $0.40 per share. After January 31, 2017, the options are exercisable under their previous terms. Subsequent to year, the Board of Directors unilaterally determined to further extend the expiration dates and reduced exercise price period to February 17, 2017. c) On December 27, 2016, the Company’s Board of Directors unilaterally determined to amend 2,375,000 stock options by extending their expiration dates. The options were granted at various dates between 2007 and 2015 and had a weighted average exercise price of $0.36 per share. The expiration dates of all of the options were extended to May 31, 2017. d) On March 25, 2016, the Company’s Board of Directors unilaterally determined to amend 3,067,197 stock options by extending their expiration dates. The options were granted at various dates between 2009 and 2014 and have a weighted average exercise price of $0.49 per share. The expiration dates of all of the options were extended to December 31, 2016. In all other respects, the terms and conditions of the options remain the same. e) On February 26, 2016, the Company granted 4,950,000 warrants to consultants exercisable at a price of $0.40 per share for a period expiring on February 28, 2020. The warrants were issued in consideration for services provided. 4,500,000 of the warrants were granted to NMC who is a related party as discussed in Note 11. During the year ended December 31, 2015, stock based compensation activity was as follows: a) On December 18, 2015, the Company’s Board of Directors unilaterally determined to amend 650,531 stock options by extending their expiration dates. The options were granted at various dates between March 8, 2010 and July 22, 2010 and have a weighted average exercise price of $0.64 per share. The expiration dates of all of the options were extended to December 31, 2016. In all other respects, the terms and conditions of the extended options remain the same. b) On April 1, 2015, the Company granted non-qualified stock options to certain executive officers under the Plan for an aggregate of 400,000 shares of common stock at an exercise price of $0.40 per option. The options vest upon completion of defined events and milestones. The options expire on the fifth anniversary of the date that they vest, but in no event later than the tenth anniversary of the agreement. Each of the options will automatically vest and become exercisable upon the occurrence of a change in control. c) On April 1, 2015, the Company granted non-qualified stock options to certain executive officers under the Plan for an aggregate of 400,000 shares of common stock at an exercise price of $0.40 per option. The options vest upon the Company’s stock price achieving defined targets. The options expire on the fifth anniversary of the date that they vest, but in no event later than the tenth anniversary of the agreement. Each of the options will automatically vest and become exercisable upon the occurrence of a change in control. d) On April 1, 2015, the Company granted non-qualified stock options to the Company’s independent directors and certain executive officers under the Plan for an aggregate of 2,700,000 shares of common stock at an exercise price of $0.40 per option. The options vest 25% each on April 1, 2015, September 30, 2015, September 30, 2015 and December 31, 2015. The options expire on the fifth anniversary of the date that they vest. The options will automatically vest and become exercisable upon the occurrence of a change in control. e) On February 25, 2015, the Company’s Board of Directors unilaterally determined to amend 650,531 stock options by extending their expiration dates. The options were granted at various dates between March 8, 2010 and July 22, 2010 and have a weighted average exercise price of $0.64 per share. The expiration dates of all of the options were extended to December 31, 2015. In all other respects, the terms and conditions of the extended options remain the same. The total expense related to the granting, vesting and modification of all stock-based compensation awards was $1,122,328 and $500,194 for the years ended December 31, 2016 and 2015, respectively. Such expenses are included in general and administrative expense and mineral exploration and evaluation expense. For the year ended December 31, 2015, the Company received $10,000 from the exercise of stock options; the related tax benefit amounted to $13,300 and the intrinsic value was $38,000. For the year ended December 31, 2016, no stock options were exercised. The following table summarizes the Company’s stock-based compensation activity for the years ended December 31, 2016 and 2015: Weighted Weighted Average Average Remaining Grant Weighted Contractual Aggregate Number of Date Fair Average Life Intrinsic Shares Value Exercise Price (Years) Value Outstanding, December 31, 2014 17,054,697 0.32 0.58 3.17 Options/warrants granted 3,500,000 0.15 0.40 5.69 Options/warrants expired (512,500 ) 0.19 0.49 - Options/warrants exercised (200,000 ) 0.38 0.05 - Outstanding, December 31, 2015 19,842,197 $ 0.30 $ 0.56 2.90 Options/warrants granted 13,020,000 0.10 0.20 4.72 Options/warrants expired (1,300,000 ) 0.31 0.65 - Options/warrants exercised - - - - Outstanding, December 31, 2016 31,562,197 $ 0.20 $ 0.41 2.92 $ 375,300 Exercisable, December 31, 2016 20,212,197 $ 0.28 $ 0.50 1.46 $ 133,200 Aggregate intrinsic value represents the value of the Company’s closing stock price on the last trading day of the year ended in excess of the weighted-average exercise price multiplied by the number of options outstanding or exercisable. Of the options/warrants outstanding at year end, 18,717,197 were granted a temporary reduction in their exercise price to $0.08 for a period ending January 31, 2017 and subsequently extended to February 17, 2017. The temporary reduction is not reflected in the table above. The following table summarizes the changes of the Company’s stock-based compensation awards subject to vesting during the year ended December 31, 2016: Weighted Average Number of Grant Date Shares Fair Value Unvested, December 31, 2015 4,230,000 $ 0.27 Granted 8,070,000 0.06 Expired (950,000 ) 0.29 Vested - - Unvested, December 31, 2016 11,350,000 $ 0.12 As of December 31, 2016, there was $498,266 of total unrecognized compensation cost related to unvested stock-based compensation awards. The weighted average period over which this cost will be recognized was 0.78 years as of December 31, 2016. Of the unvested options outstanding at year end, 3,280,000 were granted a temporary reduction in their exercise price to $0.08 for a period ending January 31, 2017 and subsequently extended to February 17, 2017. Additionally, all vesting conditions were temporarily removed for the same periods. The temporary modifications are not reflected in the table above. |